SEATTLE — In this video, Eleonora M. Lad, MD, PhD, discusses how targeting abnormalities in Bruch’s membrane in patients with age-related macular degeneration may aid in the development of treatments. In a session co-moderated by Christopher B. Toomey, MD, PhD, at the ARVO annual meeting, experts discussed new developments in understanding Burch’s membrane. The membrane serves as a filter and barrier and is affected by aging, according to Lad, vice chair of ophthalmology clinical research at Duke Health. “[Toomey’s] lab found that Bruch’s membranes in early